FDA Week - 10/13/2017

Expert says legal challenge would be difficult . . .

AAM Weighs Options On California Drug Pricing Law

October 12, 2017
Top pharmaceutical trade groups haven't yet said they will sue over California's newly signed drug pricing law, but the generics trade group tells Inside Health Policy it is weighing its options. One drug pricing expert who has advocated for similar legislation says the California law is less susceptible to the patent law and Takings Clause challenges faced by other states' drug-pricing laws, but multiple industry trade groups allege the California law raises trade secret concerns. Governor Jerry Brown signed Monday...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.